• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Zyversa Therapeutics Unveils 2025 Financials And Business Update

    GLOBENEWSWIRE

    ZyVersa CEO`s Mid-Year Letter Highlights Corporate & R&D Develop

    GLOBENEWSWIRE

    ZyVersa Therapeutics Reports Q1 2025 Financial Results & Pipeline

    GLOBENEWSWIRE

    ZyVersa Therapeutics Reports 2024 Financial Results & Update

    GLOBENEWSWIRE

    ZyVersa’s NLRP3 Inhibitor Shows HFpEF, Diabetes Benefits In Study

    GLOBENEWSWIRE

    ZyVersa Therapeutic Publishes IC 100 Data Showing Stroke Protection

    GLOBENEWSWIRE

    ZyVersa Highlights Data on Inflammasome Inhibition in Diabetes

    GLOBENEWSWIRE

    ZyVersa CEO, Issues Letter to Highlights Obesity Plans For ASC IC 100

    GLOBENEWSWIRE

    ZyVersa Therapeutics Announces Publication Demonstrating That Plasma Levels of NLRP3 Inflammasomes Correlate with Progression of Diabetic Kidney Disease

    GLOBENEWSWIRE

    ZyVersa Announces Publication Showing IC 100 Reduces Inflammasome Activation

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.